or Try an Advanced Search...

    Technical Analysis for BIOA - BioAge Labs, Inc.

    Grade Last Price % Change Price Change
    F 5.24 2.54% 0.13
    BIOA closed down 4.13 percent on Wednesday, January 22, 2025, on 15 percent of normal volume.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A Down Up
    Historical BIOA trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 2.54%
    Inside Day Range Contraction 2.54%
    Wide Bands Range Expansion 2.54%
    Outside Day Range Expansion -1.69%
    Wide Bands Range Expansion -1.69%
    Up 3 Days in a Row Strength -1.69%
    Up 4 Days in a Row Strength -1.69%
    1,2,3 Retracement Bearish Bearish Swing Setup 1.95%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.95%
    NR7 Range Contraction 1.95%
    Older End-of-Day Signals for BIOA ...

       Recent Intraday Alerts

    Alert Time
    Up 3% about 1 hour ago
    Up 2% about 1 hour ago
    Up 1% about 1 hour ago
    10 DMA Support about 1 hour ago
    Down 3% about 1 hour ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    BIOA Chart by TradingView

    Profile

    • Earnings date: Unknown
    BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Richmond, CA.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biopharmaceutical Medication Obesity Therapeutic Products Metabolic Disease Nutrition Bariatrics

    Is BIOA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 22 After an obesity stumble, BioAge reconnects with its longevity pipeline
    Jan 13 Novartis And BioAge Team Up To Develop Aging Therapies And Boost Investor Potential
    Jan 2 BioAge Labs, Inc. (BIOA) Loses -67.99% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
    Dec 27 BioAge Labs, Inc. (BIOA): A Bull Case Theory
    Dec 19 BioAge and Novartis seek drug targets for ageing-related diseases
    Dec 18 BioAge, Novartis team up to discover age-related disease targets
    Dec 18 BioAge Labs Announces Multi-Year Collaboration with Novartis to Discover Novel Targets for Therapies that Address Age-Related Diseases and Conditions
    Dec 16 3 closely watched drugs that failed in the clinic
    Dec 9 BioAge halts ongoing Phase II trial of obesity drug due to liver concerns
    Dec 9 Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
    See more BIOA news...

    Comments

    Indicators

    Indicator Value
    52 Week High 26.62
    52 Week Low 3.85
    Average Volume 838,636
    200-Day Moving Average 0.00
    50-Day Moving Average 11.07
    20-Day Moving Average 5.40
    10-Day Moving Average 5.03
    Average True Range 0.76
    RSI (14) 34.21
    ADX 37.43
    +DI 16.15
    -DI 31.14
    Chandelier Exit (Long, 3 ATRs) 4.86
    Chandelier Exit (Short, 3 ATRs) 6.26
    Upper Bollinger Bands 6.28
    Lower Bollinger Band 4.52
    Percent B (%b) 0.34
    BandWidth 32.61
    MACD Line -1.48
    MACD Signal Line -1.94
    MACD Histogram 0.465
    Fundamentals Value
    Market Cap 174.59 Million
    Num Shares 34.2 Million
    EPS -5.40
    Price-to-Earnings (P/E) Ratio -0.95
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 5.49
    Resistance 3 (R3) 5.51 5.42 5.42
    Resistance 2 (R2) 5.42 5.32 5.40 5.40
    Resistance 1 (R1) 5.26 5.26 5.22 5.24 5.38
    Pivot Point 5.17 5.17 5.14 5.15 5.17
    Support 1 (S1) 5.01 5.07 4.97 4.99 4.84
    Support 2 (S2) 4.92 5.01 4.90 4.82
    Support 3 (S3) 4.76 4.92 4.80
    Support 4 (S4) 4.74